You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Real Time Signal State Transition Software for ATC- NTCIP Interface

    SBC: Advanced Technologies, Inc            Topic: 06FH1

    Phase II Project Scope: ATI has developed an open source Signal Control Programming Environment (SCOPE) that ➢ Implements Actuated Control with Min Recall Mode, Max Recall Mode, Gap Out Mode, Max Out Mode, Presence Mode, Lane-by-Lane Control. ➢ Contains a Pretimed Mode allowing control of 3-leg, 4-leg, and Texas Diamond Intersections ➢ Can be easily ported to any operating system. ➢ Can ha ...

    SBIR Phase II 2012 Department of Transportation
  2. Reduction of Dietary Oxalate

    SBC: CAPTOZYME LLC            Topic: NCCAM

    DESCRIPTION (provided by applicant): Kidney stones are a common and painful human health care problem worldwide. Of all stones developed approximately 75% are composed of calcium oxalate. Urinary oxalate is regarded as a driving force for calcium oxalate stone formation, and absorption of dietary oxalate contributes to 10-70% of urinary oxalate. In fact, roughly 2.4 million Americans (0.75% of the ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  3. Development of Wnt Pathway Inhibitors for Colorectal Cancer

    SBC: Stemsynergy Therapeutic            Topic: NCI

    DESCRIPTION (provided by applicant): StemSynergy Therapeutics Inc. (SSTI) is a biopharmaceutical company focused on the discovery, development, and commercialization of drugs that target pathways fundamental to stem cells and cancer stem cells. The WorldHealth Organization estimates that over 12 million cases of cancer were diagnosed in 2007 and that nearly 8 million cancer patients will die of t ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  4. Quick-Set Material-Phase II

    SBC: PRIMUS CONSULTING            Topic: NIDCR

    DESCRIPTION (provided by applicant): Quick-Set Material- Phase II Quick-Set material is proposed for vital pulp therapy and for non-vital endodontic use to make the clinical procedures shorter and more consistent, of benefit to the patient and clinician,and enhance the probability for a positive outcome. The new material should promote regeneration of the periodontal ligament and cemental tissues ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  5. A perfluorocarbon-based culture device for beta cell biology applications (Phase

    SBC: Ophysio Inc.            Topic: NIDDK

    ABSTRACT Conventional culture vessels are not designed for physiological oxygen delivery. Both hyperoxia and hypoxia - commonly observed when culturing cells and tissues in regular plasticware- have been linked to reduced cellular function and death. An adequate means to provide oxygenation is also critical for stem cell applications in which the differentiation outcome is dependent on oxygen ten ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  6. Safety and Efficacy of Single-use Cliradex Pads for Ocular Mites

    SBC: BIOTISSUE HOLDINGS INC.            Topic: NEI

    DESCRIPTION (provided by applicant): Demodex mites are microscopic ectoparasites that commonly infest the pilosebaceous unit of the skin. Uncontrolled overgrowth of mites has been implicated in causing papulopustular lesions in the skin, rosacea in the face, and blepharitis in the eye. Blepharitis (lid margin inflammation) associated with mite-harboring cylindrical dandruff in eyelashes is one of ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  7. Amniotic Membrane versus Pericardium in Reducing Glaucoma Drainage Tube Exposure

    SBC: BIOTISSUE HOLDINGS INC.            Topic: NEI

    DESCRIPTION (provided by applicant): Glaucoma drainage devices (GDDs) have widely been used in the treatment of high-risk refractory glaucoma. To avoid tube exposure, which may lead to serious eye infection, the implanted GDD tube must be covered by apatch graft traditionally made of either donor sclera or pericardium. However, these patch grafts still carry a high rate of progressive thinning ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  8. Virtual Emergency Medical Technician-Basic Training Program

    SBC: ARCHIE MD INC.            Topic: NHLBI

    DESCRIPTION (provided by applicant): ZetrOZ has developed a prototype novel, miniature, portable, high-power, ultrasound system for would healing. Wound healing is a major clinical issue, and can present significant clinical challenges both when wounds areacute--occurring due to trauma, burns, surgery, or due to more chronic health problems. Wound healing is an intricate fibroproliferative respons ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  9. Augmented Reality Simulation for Teaching Medical Students

    SBC: ARCHIE MD INC.            Topic: OD

    DESCRIPTION (provided by applicant): Currently, the physician workforce is aging and average hours worked is falling compared to historical levels. In addition, the physician-to-population ratio is beginning to plateau, and is expected to decline right asthe U.S. elderly (and more medically needy) population is on the rise. Thus, the physician workforce may not be able fulfill the U.S. population ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  10. Pilot PK Study with a Novel Nicotine Replacement Therapy for Smoking Cessati

    SBC: PHARMACEUTICAL PRODUCTIONS, INC.            Topic: NIDA

    DESCRIPTION (provided by applicant): The proposed Proof of Concept Study seeks Phase I STTR funding to support a novel nicotine replacement therapy (NRT) pilot pharmacokinetic (PK) trail in healthy smokers. Very little by way of product development has occurred in the NRT field despite scientists' and clinicians' pleas for improved NRTs, specifically for a faster-acting NRT that resemble ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government